← Back to headlines
Wave Stock Hits 52-Week Low Following Obesity Drug Data Reaction
Wave's stock has fallen to a 52-week low as analysts react to new data concerning the company's obesity drug.
26 Mar, 18:38 — 26 Mar, 18:38
Sources
Showing 1 of 1 sources
Related Stories
400-Year-Old Barrels Discovered in Norway Reveal City's Reconstruction Methods
33m ago
Blood Pressure Readings May Predict Dementia Risk Years Before Symptoms
41m ago
Study Finds AI Language Models Dangerously Submissive in Social Conflicts
52m ago
Radar Scans at Giza Plateau Suggest Vast Underground Network, Possible Second Sphinx
54m ago